Nurix Therapeutics NRIX
NASDAQ NRIX
$23.71 +0.03 (+0.15%)
At close: Sep 30, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Other Non-Current Assets (2019 - 2026)

Updated

Nurix Therapeutics' Other Non-Current Assets was $7.98 million in fiscal Q2 2026 (quarter ended May 31, 2026), up 785.3% from $901,000 a year earlier and up 7.6% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Other Non-Current Assets (2019 - 2026) Analysis & Trends

At the end of FY2025 (ended Nov 30, 2025), Other Non-Current Assets at Nurix Therapeutics came in at $7.34 million, up 132.4% from FY2024.

  • Other Non-Current Assets shows a five-year compound annual growth rate of 105.6% (FY2020 to FY2025).
  • In earlier fiscal years, Other Non-Current Assets was $3.16 million in FY2024 (+250.6%), $901,000 in FY2023 (unchanged), $901,000 in FY2022 (-68.2%) and $2.83 million in FY2021.
  • The fiscal Q2 2026 figure marks the highest quarterly Other Non-Current Assets in data going back to fiscal Q3 2019.
  • Compared with a year earlier, Other Non-Current Assets has increased for four straight quarters, with growth averaging 326.2% over the last eight quarters.
  • The best year-over-year quarter for Other Non-Current Assets over five years was fiscal Q2 2026 (growth of 785.3%); the worst was fiscal Q3 2022 (a decline of 72.6%).
  • Per Business Quant data, NRIX's Other Non-Current Assets in the three fiscal quarters before Q2 2026 was $7.41 million (Q1 2026), $7.34 million (Q4 2025) and $7.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 14.27 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.73 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 4.75 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.25 Bn
10 Nurix Therapeutics 2.45 Bn 448.58 Mn - 7.98 Mn
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 7.98 Mn
Feb 28, 2026 7.41 Mn
Nov 30, 2025 7.34 Mn
Aug 31, 2025 7.38 Mn
May 31, 2025 901,000.00
Feb 28, 2025 901,000.00
Nov 30, 2024 3.16 Mn
Aug 31, 2024 901,000.00
May 31, 2024 901,000.00
Feb 29, 2024 901,000.00
Nov 30, 2023 901,000.00
Aug 31, 2023 901,000.00
May 31, 2023 901,000.00
Feb 28, 2023 901,000.00
Nov 30, 2022 901,000.00
Aug 31, 2022 901,000.00
May 31, 2022 901,000.00
Feb 28, 2022 901,000.00
Nov 30, 2021 2.83 Mn
Aug 31, 2021 3.29 Mn
API Access

Nurix Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NRIX&period=max&api_key=YOUR_API_KEY